Patrick L Iversen

InstitutionUSAMRID
AddressFort Detrick
Maryland
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 1 publications in January 2020 and February 2021 and March 2021 and August 2021
    All Publications
    Bar chart showing 139 publications over 25 distinct years, with a maximum of 14 publications in 2006 and 2007
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Iversen PL, Bavari S. Extending the interval of COVID-19 vaccine regimens in individuals aged 80 years or older. Lancet Healthy Longev. 2021 Sep; 2(9):e529-e530. PMID: 34430953.
      Citations:    
    2. Iversen PL, Bavari S. Is there space for a three-dose vaccine to fight the spread of SARS-CoV-2? Lancet Infect Dis. 2021 08; 21(8):1054-1055. PMID: 33773112.
      Citations: 2     Fields:    Translation:Humans
    3. Iversen PL, Bavari S. Inactivated COVID-19 vaccines to make a global impact. Lancet Infect Dis. 2021 06; 21(6):746-748. PMID: 33548196.
      Citations: 8     Fields:    Translation:Humans
    4. Kipshidze N, Iversen P, Iversen P, Porter TR, Kipshidze N, Siddiqui F, Dangas G, Fareed J. Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620954911. PMID: 32936689.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    5. Moulton HM, Fletcher S, Neuman BW, McClorey G, Stein DA, Abes S, Wilton SD, Buchmeier MJ, Lebleu B, Iversen PL. Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo. Biochem Soc Trans. 2007 Aug; 35(Pt 4):826-8. PMID: 17635157.
      Citations: 29     Fields:    Translation:HumansAnimalsCells
    6. Burrer R, Neuman BW, Ting JP, Stein DA, Moulton HM, Iversen PL, Kuhn P, Buchmeier MJ. Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models. J Virol. 2007 Jun; 81(11):5637-48. PMID: 17344287.
      Citations: 38     Fields:    Translation:AnimalsCells
    7. Neuman BW, Stein DA, Kroeker AD, Moulton HM, Bestwick RK, Iversen PL, Buchmeier MJ. Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers. Adv Exp Med Biol. 2006; 581:567-71. PMID: 17037599.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    8. Neuman BW, Stein DA, Kroeker AD, Churchill MJ, Kim AM, Kuhn P, Dawson P, Moulton HM, Bestwick RK, Iversen PL, Buchmeier MJ. Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers. J Virol. 2005 Aug; 79(15):9665-76. PMID: 16014928.
      Citations: 45     Fields:    Translation:AnimalsCells
    9. Neuman BW, Stein DA, Kroeker AD, Paulino AD, Moulton HM, Iversen PL, Buchmeier MJ. Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth. J Virol. 2004 Jun; 78(11):5891-9. PMID: 15140987.
      Citations: 31     Fields:    Translation:AnimalsCells